1050 Constitution Colleen Lubic Media Contact
Exhibit 99 News Release Axalta Coating Systems Investor Contact 1050 Constitution Colleen Lubic Media Contact Avenue D +1 610-999-9407 axalta-media-relat… Philadelphia, PA Colleen.Lubic@axa… 19112 USA
PHILADELPHIA, PA, October 29, 2026 - Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the third quarter ended September 30, 2026.
▪ Cash provided by operating activities of $135 million, in line with prior year
“Axalta delivered another quarter of revenue growth, strong cash generation and robust profitability despite a more challenging operating environment,” said Chris Villavarayan, Chief Executive Officer and President of Axalta. “We maintained Adjusted EBITDA margin above 20%, further strengthened our balance sheet and achieved record quarterly net sales in Mobility Coatings. As we look ahead, we remain focused on disciplined execution and are confident in the significant value creation opportunity associated with our proposed combination with AkzoNobel.”
Third quarter 2026 net sales increased 2% to $1.3 billion driven by volume growth in three out of four regions, favorable foreign currency translation, contributions from acquisitions and positive price mix, partially offset by volume declines primarily in Europe.
Net income decreased by $15 million year over year to $95 million resulting in a net income margin of 7.2%. The decrease was primarily driven by an incremental $14 million in merger and acquisition-related expenses in the current-year period. Adjusted net income, which excludes merger and acquisition-related expenses, decreased 6% year over year to $136 million driven by lower volumes in Performance Coatings and higher raw material and freight costs, partially offset by reduced operating expenses, favorable price mix and lower interest expense.
Adjusted EBITDA was $282 million, a decrease of 4% compared to the prior-year period, resulting in an Adjusted EBITDA margin of 21.5%. Diluted EPS was $0.44 compared to $0.51 in the prior-year period, reflecting lower volumes in Performance Coatings and higher merger and acquisition-related expenses. Adjusted Diluted EPS was $0.63, down 6% year over year, as lower volumes and higher variable costs were partially offset by lower interest expense resulting from the Company's continued deleveraging efforts.
Cash provided by operating activities was $135 million, in line with the prior- year period, and free cash flow increased 3% year over year to $92 million, inclusive of approximate ly $21 million of incremental merger and acquisition- related cash costs incurred during the quarter.
Performance Coatings net sales were $818 million in the third quarter, dow n $10 million year over year, as lower Refinish volumes in Europe more than offset favorable foreign currency translation, contributions from acquisitions and positive price mix. Outside of Europe, demand trends across Performance Coatings remained generally stable, with net sales down low single digits in North America and up high single digits in both Latin America and Asia Pacific, continuing the growth momentum established over the last four quarters in such regions. 1 Refinish net sales declined 2% year over year to $504 million, primarily driven by lower volumes in Europe, partially offset by contributions from acquisitions and favorable price mix. Industrial net sales increased by 1% year over year to $314 million, primarily driven by volume growth in Asia Pacific.
Performance Coatings Adjusted EBITDA was $188 million compared with $211 million in the prior-year period. The decrease was driven by lower volumes, variable cost inflation and investments supporting recently awarded business wins, partially offset by lower operating expenses, pricing actions and contributions from acquisitions. Adjusted EBITDA margin was 23.0%, compared to 25.5% in the prior-year period.
Mobility Coatings achieved record quarterly net sales of $493 million, up 7% year over year. Light Vehicle net sales were up 2%, driven primarily by favorable foreign currency translation. Commercial Vehicle net sales increased 24% year over year to $119 million, driven by volume growth resulting from an increase in Class 8 production in North America.
Mobility Coatings delivered Adjusted EBITDA of $94 million, a third quarter record, with Adjusted EBITDA margin of 19.0% refle cting 100 basis points of margin expansion year over year. Stronger volumes and lower operating expenses more than offset variable cost inflation and unfavorable price mix.
(in millions, except %’s and per share Projection data) Item Q4 2026 FY 2026 Net Sales (YoY % growth) ~FLAT LSD% Adjusted EBITDA $254 - $264 $1,100 - $1,110 Adjusted Diluted EPS ~$0.55 ~$2.45 Free Cash Flow(1) ~$450 Depreciation and Amortization $310 Tax Rate, As Adjusted ~24% Diluted Shares Outstanding ~215 Interest Expense ~$150 Capital Expenditures ~$200
Axalta does not provide a reconciliation for non-GAAP estimates for Adjusted EBITDA, Adjusted Diluted EPS, Free Cash Flow or tax rate, as adjusted, on a forward-looking basis because the information necessary to calculate a meaningful or accurate estimation of reconciling items is not available without unreasonable effort. See “Non-GAAP Financial Measures” for more information.
As previously announced, Axalta will hold a conference call to discuss its third quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 a.m. ET. A live webcast of the conference call will be available online at www.axalta.com/investorcall . A replay of the webcast will be posted shortly after the call and will remain accessible through October 29, 2027. The dial-in phone number for the conference call is 1-800-445-7795 and the conference ID is AXALTA. For those unable to participate, a replay will be available through November 5, 2026. The replay dial-in number is +1-844-512-2921. The replay passcode is 11162641.
This release may contain certain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 regarding Axalta and its subsidiaries including, but not limited to, our outlook and/or guidance, which includes net sales growth, Adjusted EBITDA, Adjusted Diluted EPS, Free Cash Flow, depreciation and amortization, tax rate, as adjusted, diluted shares outstanding, interest expense and capital expenditures and statements regarding the proposed merger of equals (the “Proposed Merger”) with Akzo Nobel N.V. (“AkzoNobel”) (including our ability to consummate the Proposed Merger and realize the anticipated benefits thereof). Axalta has identified some of these forward-looking statements with words 2 such as “outlook,” “proposed,” “opportunity,” “confident,” “anticipated,” “momentum,” and “projection,” and the negative of these words or other comparable or similar terminology. All of these statements are based on management’s expectations as well as estimates and assumptions prepared by management that, although they believe to be reasonable, are inherently uncertain. These statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental (including related to any new or existing tariffs imposed by the U.S. and any retaliatory actions from other countries), geopolitical (including the current conflict in the Middle East and related effects on raw material and freight prices, as well as mitigation strategies developed in response thereto) and technological factors outside of Axalta’s control, as well as risks related to the execution of, and assumptions underlying, our tariff mitigation strategies, our capital allocation strategy and future share repurchases, our previously-announced global transformation initiative, our previously-announced three-year 2024-2026 strategy, the Proposed Merger (including our ability to consummate the Proposed Merger and realize the anticipated benefits thereof) and our planned divestiture of our North America Building Products business that may cause its business, industry, strategy, financing activities or actual results to differ materially. More information on potential factors that could affect Axalta’s financial results is available in “Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” within Axalta’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and in other documents that we have filed with, or furnished to, the U.S. Securities and Exchange Commission (the “SEC”). More information on these risks, as well as other risks associated with the Proposed Merger, are also discussed in the definitive proxy statement/prospectus relating to the Proposed Merger, which was filed with the SEC on June 24, 2026. Axalta undertakes no obligation to update or revise any of the forward-looking statements contained herein, whether as a result of new information, future events or otherwise.
This release includes financial information that is not presented in accordance with generally accepted accounting principles in the United States (“GAAP”), including Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, Free Cash Flow, total net leverage ratio (or “total net leverage”), tax rate, as adjusted, and Adjusted EBIT. Management uses Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, tax rate, as adjusted, and Adjusted EBIT in the analysis of our financial and operating performance because they assist in the evaluation of underlying trends in our business. Management uses Free Cash Flow and total net leverage ratio in the analysis of (1) our liquidity, (2) our ability to incur and service our debt and (3) strategic capital allocation decisions. Adjusted EBITDA, Adjusted Diluted EPS, adjusted net income and Adjusted EBIT consist of EBITDA, Diluted EPS, net income attributable to common shareholders and EBIT, respectively, adjusted for (i) certain non-cash items included within net income, (ii) certain items Axalta does not believe are indicative of ongoing operating performance or (iii) certain nonrecurring, unusual or infrequent items that have not otherwise occurred within the last two years or we believe are not reasonably likely to recur within the next two years. Free Cash Flow consists of cash provided by (used for) operating activities less purchase of property, plant and equipment plus interest proceeds on swaps designated as net investment hedges. Total net leverage ratio consists of net debt divided by Adjusted EBITDA, with net debt defined as total debt less cash and cash equivalents. We believe that making the foregoing adjustments provides investors meaningful information to understand our operating results and ability to analyze financial and business trends on a period-to-period basis. The non-GAAP financial measures used by Axalta may differ from similarly titled measures reported by other companies. Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, Free Cash Flow, total net leverage ratio, tax rate, as adjusted, and Adjusted EBIT should not be considered as alternatives to net sales, net income (loss), income (loss) from operations or any other financial measures derived in accordance with GAAP. These non-GAAP financial measures have important limitations as analytical tools and should be considered in conjunction with, and not as substitutes for, our results as reported under GAAP. This release includes a reconciliation of certain non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP. Axalta does not provide a reconciliation for Adjusted EBITDA, Adjusted Diluted EPS, tax rate, as adjusted, or Free Cash Flow on a forward-looking basis because the information necessary to calculate a meaningful or accurate estimation of reconciling items is not available without unreasonable effort. For example, such reconciling items include the impact of foreign currency exchange gains or losses, gains or losses that are unusual or nonrecurring in nature, as well as discrete taxable events. These items are uncertain, depend on various factors and may have a substantial and unpredictable impact on our GAAP results.
The primary measure of segment operating performance is Adjusted EBITDA, which is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts and prior year financial results and that management believes reflects Axalta’s core operating performance. As we do not measure segment operating performance 3 based on net income, a reconciliation of this non-GAAP financial measure with the most directly comparable financial measure calculated in accordance with GAAP is not available.
All capitalized terms contained within this release that are not otherwise defined herein have been previously defined in our filings with the SEC.
Certain amounts may not foot or crossfoot due to rounding. Additionally, certain percentages may not recalculate due to rounding.
This communication is not for release, publication, or distribution, in whole or in part, in or into, directly or indirectly, any jurisdiction in which such release, publication, or distribution would be unlawful.
This communication is not a prospectus and the information in this communication is not intended to be complete. This communication is for informational purposes only and is not intended to be and shall not constitute a solicitation of any vote or approval, or an offer to buy or sell, or the solicitation of an offer to buy or sell, any securities, or an invitation or recommendation to subscribe for, acquire or buy securities of Axalta or AkzoNobel or any other financial products or securities, in any place or jurisdiction, nor shall there be any offer, solicitation or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended (the “Securities Act”).
Any decision to purchase, subscribe for, otherwise acquire, sell or otherwise dispose of any securities must be made only on the basis of the information contained in and incorporated by reference into the prospectus with respect to the shares to be allotted by AkzoNobel in the Proposed Merger, which was published on June 24, 2026 and supplemented on July 22, 2026.
The distribution of this communication may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this document should inform themselves of and observe these restrictions. To the fullest extent permitted by applicable law, Axalta and AkzoNobel disclaim any responsibility or liability for the violation of any such restrictions by any person. Neither Axalta, nor AkzoNobel, nor any of their advisors assume any responsibility for any violation by any person of any of these restrictions. Shareholders of Axalta and AkzoNobel, respectively, with any doubt as to their position should consult an appropriate professional advisor without delay.
This communication is addressed to and directed only at (i) persons who are outside the United Kingdom, (ii) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (iii) persons falling within Article 49(2)(a) to (d) of the Order, or (iv) persons to whom it may otherwise lawfully be communicated pursuant to the Order (all such persons together being referred to as, “Relevant Persons”). This communication is directed only at Relevant Persons. Other persons should not act or rely on this communication or any of its contents. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with such persons. Solicitations resulting from this communication will only be responded to if the person concerned is a Relevant Person.
In connection with the Proposed Merger between Axalta and AkzoNobel, AkzoNobel filed with the SEC a registration statement on Form F-4 on May 27, 2026, as amended on June 18, 2026, which included a proxy statement of Axalta that also constitutes a prospectus with respect to the shares to be offered by AkzoNobel in the Proposed Merger. The registration statement was declared effective by the SEC on June 23, 2026. In connection with the proposed transaction, on June 24, 2026, Axalta filed with the SEC a definitive proxy statement and, on or about June 24, 2026, Axalta commenced mailing the definitive proxy statement to its holders of record as of June 11, 2026. On August 5, 2026, shareholders at the Extraordinary General Meeting of AkzoNobel and the Special General Meeting of Axalta, respectively, voted in favor of all resolutions related to the Proposed Merger. Each of Axalta and AkzoNobel will also file other relevant documents in connection with the Proposed Merger. This communication is not a substitute for any registration statement, proxy statement/prospectus or other documents Axalta and/or AkzoNobel may file with the SEC or any other competent regulator in connection with the Proposed Merger. This communication does not contain all the information that should be considered concerning the Proposed Merger and is not intended to form the basis of any investment decision or any other decision in respect of the Proposed Merger. BEFORE MAKING ANY VOTING OR INVESTMENT DECISIONS, INVESTORS, STOCKHOLDERS AND 4 SHAREHOLDERS OF AXALTA AND AKZONOBEL ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT/PROSPECTUS, AS APPLICABLE, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE, AS THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT AXALTA, AKZONOBEL, THE PROPOSED TRANSACTION AND RELATED MATTERS. The registration statement and proxy statement/prospectus and other relevant documents filed by Axalta and AkzoNobel with the SEC are available free of charge at the SEC’s website at www.sec.gov. In addition, investors and shareholders will be able to obtain free copies of the proxy statement/prospectus and other documents filed with the SEC from Axalta’s investor relations webpage at https://ir.axalta.com/sec-filings/all-sec-filings or from AkzoNobel’s investor relations webpage at https://www.akzonobel.com/en/investors/all-sec-filings.
The contents of this communication should not be construed as financial, legal, business, investment, tax or other professional advice. Each recipient should consult with its own professional advisors for any such matter and advice
Axalta is a global leader in the coatings industry, providing customers with innovative, colorful, beautiful and sustainable coatings solutions. From light vehicles, commercial vehicles and refinish applications to electric motors, building facades and other industrial applications, our coatings are designed to prevent corrosion, increase productivity and enhance durability. With more than 150 years of experience in the coatings industry, the global team at Axalta continues to find ways to serve our more than 100,000 customers in over 140 countries better every day with the finest coatings, application systems and technology. For more information visit axalta.com and follow us @axalta on X. 5
Financ… Statem… Tables AXALTA COATING SYSTEMS LTD. Conden… Consol… Statem… of Operat… (Unaud… (In millio… except per share data) Three Nine Months Months Ended Ended September Septemb… 30, 30, 2026 2025 2026 2025 Net $ 1,311 $ 1,288 $ 3,911 $ 3,855 sales Cost of goods 877 838 2,596 2,515 sold Sellin… general and 201 197 614 607 admini… expens… Other operat… 24 6 92 32 charges Resear… and 18 18 54 55 develo… expens… Amorti… of 26 25 77 73 acquir… intang… Income from 165 204 478 573 operat… Intere… expens… 37 45 112 134 net Other expense — 4 -1 12 (incom… net Income before 128 155 367 427 income taxes Provis… for 33 45 92 108 income taxes Net 95 110 275 319 income Less: Net income attrib… — — 1 1 to noncon… intere… Net income attrib… $ 95 $ 110 $ 274 $ 318 to common shareh… Basic net income $ 0.44 $ 0.51 $ 1.28 $ 1.47 per share Diluted net income $ 0.44 $ 0.51 $ 1.28 $ 1.46 per share Basic weight… average 214.0 215.0 213.9 216.9 shares outsta… Diluted weight… average 215.1 215.9 214.8 217.9 shares outsta…
AXALTA COATING SYSTEMS LTD. Condensed Consolidated Balance Sheets (Unaudited) (In millions, except per share data) Assets Current assets: September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── Cash and cash $ 650 $ 657 equivalents Restricted cash 6 3 Accounts and notes receivable, 1,366 1,229 net Inventories 849 756 Prepaid expenses and other current 192 170 assets Total current 3,063 2,815 assets Property, plant and equipment, 1,319 1,299 net Goodwill 1,762 1,795 Identifiable 1,056 1,147 intangibles, net Other assets 547 543 Total assets $ 7,747 $ 7,599 Liabilities, Shareholders’ Equity Current liabilities: Accounts payable $ 780 $ 637 Current portion 519 20 of borrowings Other accrued 701 712 liabilities Total current 2,000 1,369 liabilities Long-term 2,476 3,179 borrowings Accrued pensions 225 238 Deferred income 182 171 taxes Other liabilities 198 249 Total liabilities 5,081 5,206 Shareholders’ equity: Common shares, $1.00 par, 1,000.0 shares authorized, 255.7 and 255.1 shares issued at 256 255 September 30, 2026 and December 31, 2025, respectively Capital in excess 1,637 1,621 of par Retained earnings 2,329 2,055 Treasury shares, at cost, 41.7 shares at both September -1,202 -1,202 30, 2026 and December 31, 2025 Accumulated other comprehensive -400 -383 loss Total Axalta shareholders’ 2,620 2,346 equity Noncontrolling 46 47 interests Total shareholders’ 2,666 2,393 equity Total liabilities and shareholders’ $ 7,747 $ 7,599 equity
AXALTA COATING SYSTEMS LTD. Condensed Consolidated Statements of Cash Flows (Unaudited) Nine Months Ended (In millions) September 30, Operating activities: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 275 $ 319 Adjustment to reconcile net income to cash provided by operating activities: Depreciation and amortization 233 218 Amortization of deferred financing costs 6 6 and original issue discount Deferred income taxes 24 28 Realized and unrealized foreign exchange -8 31 (gains) losses, net Stock-based compensation 23 19 Interest income on swaps designated as -9 -9 net investment hedges Other non-cash, net -2 8 Changes in operating assets and liabilities: Trade accounts and notes receivable -132 -48 Inventories -99 -53 Prepaid expenses and other assets -75 -132 Accounts payable 146 -15 Other accrued liabilities 2 -71 Other liabilities -29 4 Cash provided by operating 355 305 activities Investing activities: Acquisitions, net of cash acquired -8 -6 Purchase of property, plant and -144 -138 equipment Interest proceeds on swaps designated as 9 9 net investment hedges Proceeds received on loans to 8 6 customers Other investing activities, net -3 7 Cash used for investing activities -138 -122 Financing activities: Payments on long-term borrowings -211 -25 Purchases of common stock — -165 Net cash flows associated with -7 -3 stock-based awards Other financing activities, net -3 -2 Cash used for financing activities -221 -195 Decrease in cash -4 -12 Effect of exchange rate changes on — 26 cash Cash at beginning of period 660 596 Cash at end of period $ 656 $ 610 Cash at end of period reconciliation: Cash and cash equivalents $ 650 $ 606 Restricted cash 6 4 Cash at end of period $ 656 $ 610
8 The following table reconciles net income to EBITDA, Adjusted EBITDA and segment Adjusted EBITDA for the periods presented (in millions):
Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other (a) employee-related costs associated with restructuring programs and other employee-related costs. We do not consider these amounts indicative of our ongoing operating performance. Represents merger and acquisition-related expenses, including costs (b) related to financial, tax and legal advisory services, associated with both consummated and unconsummated transactions, all of which we do not consider indicative of our ongoing operating performance. Represents costs related to the closure of certain manufacturing (c) sites, including impairment charges, which we do not consider indicative of our ongoing operating performance. Represents foreign exchange losses resulting from the remeasurement (d) of assets and liabilities denominated in foreign currencies, net of the impacts of our foreign currency instruments used to hedge our balance sheet exposures. (e) Represents the non-cash, non-service cost components of long-term employee benefit costs. (f) Represents non-cash impacts associated with stock-based compensation. Represents non-recurring income related to the sales of certain fixed (g) assets, which are not considered indicative of our ongoing performance. Represents (benefits) costs for certain non-operational or non-cash (h) (gains) losses, net, unrelated to our core business and which we do not consider indicative of our ongoing operating performance.
9 The following table reconciles net income to adjusted net income for the periods presented (in millions, except per share data):
Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other (a) employee-related costs associated with restructuring programs and other employee-related costs. We do not consider these amounts indicative of our ongoing operating performance. Represents merger and acquisition-related expenses, including costs (b) related to financial, tax and legal advisory services, associated with both consummated and unconsummated transactions, all of which we do not consider indicative of our ongoing operating performance. Represents incremental depreciation expense resulting from truncated useful lives of the assets impacted by our manufacturing footprint (c) assessments and costs related to the closure of certain manufacturing sites, including impairment charges, which we do not consider indicative of our ongoing operating performance. Represents (benefits) costs for certain non-operational or non-cash (d) (gains) losses, net, unrelated to our core business and which we do not consider indicative of our ongoing operating performance. (e) Represents non-cash amortization expense for intangible assets acquired through business combinations or asset acquisitions. The income tax impacts are determined using the applicable rates in the taxing jurisdictions in which expense or income occurred and includes both current and deferred income tax expense (benefit) based (f) on the nature of the non-GAAP performance measure. Additionally, the income tax impact includes the removal of discrete income tax impacts within our effective tax rate which were benefits of $0 million and $12 million and expenses of $10 million and $6 million for the three and nine months ended September 30, 2026 and 2025, respectively.
10 The following table reconciles cash provided by operating activities to free cash flow for the periods presented (in millions):
11 The following table reconciles income from operations to adjusted EBIT for the periods presented (in millions):
Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other (a) employee-related costs associated with restructuring programs and other employee-related costs. We do not consider these amounts indicative of our ongoing operating performance. Represents merger and acquisition-related expenses, including costs (b) related to financial, tax and legal advisory services, associated with both consummated and unconsummated transactions, all of which we do not consider indicative of our ongoing operating performance. Represents incremental depreciation expense resulting from truncated useful lives of the assets impacted by our manufacturing footprint (c) assessments and costs related to the closure of certain manufacturing sites, including impairment charges, which we do not consider indicative of our ongoing operating performance. Represents (benefits) costs for certain non-operational or non-cash (d) (gains) losses, net, unrelated to our core business and which we do not consider indicative of our ongoing operating performance. (e) Represents non-cash amortization expense for intangible assets acquired through business combinations or asset acquisitions.
Full text with the tables
Exhibit 99
News Release
Axalta Coating
Systems Investor Contact
1050 Constitution Colleen Lubic Media Contact
Avenue D +1 610-999-9407 axalta-media-relat…
Philadelphia, PA Colleen.Lubic@axa…
19112
USA
Immediate Release
Axalta Releases Third Quarter 2026 Results
PHILADELPHIA, PA, October 29, 2026 - Axalta Coating Systems Ltd. (NYSE:AXTA)
(“Axalta”), a leading global coatings company, announced its financial results
for the third quarter ended September 30, 2026.
Third Quarter 2026 Highlights:
▪ Net sales of $1.3 billion, an increase of 2% year over year
▪ Record quarter for Mobility net sales
▪ Net income of $95 million and net income margin of 7.2%
▪ Adjusted EBITDA of $282 million with an Adjusted EBITDA margin of 21.5%
▪ Diluted EPS of $0.44
▪ Adjusted Diluted EPS of $0.63
▪ Cash provided by operating activities of $135 million, in line with prior year
▪ Free cash flow of $92 million, up 3% year over year
▪ Total net leverage of 2.1x, the lowest in Axalta’s history
“Axalta delivered another quarter of revenue growth, strong cash generation and
robust profitability despite a more challenging operating environment,” said
Chris Villavarayan, Chief Executive Officer and President of Axalta. “We
maintained Adjusted EBITDA margin above 20%, further strengthened our balance
sheet and achieved record quarterly net sales in Mobility Coatings. As we look
ahead, we remain focused on disciplined execution and are confident in the
significant value creation opportunity associated with our proposed combination
with AkzoNobel.”
Third Quarter 2026 Consolidated Financial Results
Third quarter 2026 net sales increased 2% to $1.3 billion driven by volume
growth in three out of four regions, favorable foreign currency translation,
contributions from acquisitions and positive price mix, partially offset by
volume declines primarily in Europe.
Net income decreased by $15 million year over year to $95 million resulting in a
net income margin of 7.2%. The decrease was primarily driven by an incremental
$14 million in merger and acquisition-related expenses in the current-year
period. Adjusted net income, which excludes merger and acquisition-related
expenses, decreased 6% year over year to $136 million driven by lower volumes in
Performance Coatings and higher raw material and freight costs, partially offset
by reduced operating expenses, favorable price mix and lower interest expense.
Adjusted EBITDA was $282 million, a decrease of 4% compared to the prior-year
period, resulting in an Adjusted EBITDA margin of 21.5%. Diluted EPS was $0.44
compared to $0.51 in the prior-year period, reflecting lower volumes in
Performance Coatings and higher merger and acquisition-related expenses.
Adjusted Diluted EPS was $0.63, down 6% year over year, as lower volumes and
higher variable costs were partially offset by lower interest expense resulting
from the Company's continued deleveraging efforts.
Cash provided by operating activities was $135 million, in line with the prior-
year period, and free cash flow increased 3% year over year to $92 million,
inclusive of approximate ly $21 million of incremental merger and acquisition-
related cash costs incurred during the quarter.
Discussion of Segment Results
Performance Coatings net sales were $818 million in the third quarter, dow n $10
million year over year, as lower Refinish volumes in Europe more than offset
favorable foreign currency translation, contributions from acquisitions and
positive price mix. Outside of Europe, demand trends across Performance Coatings
remained generally stable, with net sales down low single digits in North
America and up high single digits in both Latin America and Asia Pacific,
continuing the growth momentum established over the last four quarters in such
regions.
1
Refinish net sales declined 2% year over year to $504 million, primarily driven
by lower volumes in Europe, partially offset by contributions from acquisitions
and favorable price mix. Industrial net sales increased by 1% year over year to
$314 million, primarily driven by volume growth in Asia Pacific.
Performance Coatings Adjusted EBITDA was $188 million compared with $211 million
in the prior-year period. The decrease was driven by lower volumes, variable
cost inflation and investments supporting recently awarded business wins,
partially offset by lower operating expenses, pricing actions and contributions
from acquisitions. Adjusted EBITDA margin was 23.0%, compared to 25.5% in the
prior-year period.
Mobility Coatings achieved record quarterly net sales of $493 million, up 7%
year over year. Light Vehicle net sales were up 2%, driven primarily by
favorable foreign currency translation. Commercial Vehicle net sales increased
24% year over year to $119 million, driven by volume growth resulting from an
increase in Class 8 production in North America.
Mobility Coatings delivered Adjusted EBITDA of $94 million, a third quarter
record, with Adjusted EBITDA margin of 19.0% refle cting 100 basis points of
margin expansion year over year. Stronger volumes and lower operating expenses
more than offset variable cost inflation and unfavorable price mix.
Fourth Quarter and Full Year 2026 Outlook
(in millions, except %’s and per share Projection
data)
Item Q4 2026 FY 2026
Net Sales (YoY % growth) ~FLAT LSD%
Adjusted EBITDA $254 - $264 $1,100 - $1,110
Adjusted Diluted EPS ~$0.55 ~$2.45
Free Cash Flow(1) ~$450
Depreciation and Amortization $310
Tax Rate, As Adjusted ~24%
Diluted Shares Outstanding ~215
Interest Expense ~$150
Capital Expenditures ~$200
LSD = low single digit percentage
(1) Includes ~$80M of merger and acquisition-related cash costs
Axalta does not provide a reconciliation for non-GAAP estimates for Adjusted
EBITDA, Adjusted Diluted EPS, Free Cash Flow or tax rate, as adjusted, on a
forward-looking basis because the information necessary to calculate a
meaningful or accurate estimation of reconciling items is not available without
unreasonable effort. See “Non-GAAP Financial Measures” for more information.
Conference Call Information
As previously announced, Axalta will hold a conference call to discuss its third
quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 a.m. ET. A
live webcast of the conference call will be available online at
www.axalta.com/investorcall . A replay of the webcast will be posted shortly
after the call and will remain accessible through October 29, 2027. The dial-in
phone number for the conference call is 1-800-445-7795 and the conference ID is
AXALTA. For those unable to participate, a replay will be available through
November 5, 2026. The replay dial-in number is +1-844-512-2921. The replay
passcode is 11162641.
Cautionary Statement Concerning Forward-Looking Statements
This release may contain certain forward-looking statements within the meaning
of the U.S. Private Securities Litigation Reform Act of 1995 regarding Axalta
and its subsidiaries including, but not limited to, our outlook and/or guidance,
which includes net sales growth, Adjusted EBITDA, Adjusted Diluted EPS, Free
Cash Flow, depreciation and amortization, tax rate, as adjusted, diluted shares
outstanding, interest expense and capital expenditures and statements regarding
the proposed merger of equals (the “Proposed Merger”) with Akzo Nobel N.V.
(“AkzoNobel”) (including our ability to consummate the Proposed Merger and
realize the anticipated benefits thereof). Axalta has identified some of these
forward-looking statements with words
2
such as “outlook,” “proposed,” “opportunity,” “confident,” “anticipated,”
“momentum,” and “projection,” and the negative of these words or other
comparable or similar terminology. All of these statements are based on
management’s expectations as well as estimates and assumptions prepared by
management that, although they believe to be reasonable, are inherently
uncertain. These statements involve risks and uncertainties, including, but not
limited to, economic, competitive, governmental (including related to any new or
existing tariffs imposed by the U.S. and any retaliatory actions from other
countries), geopolitical (including the current conflict in the Middle East and
related effects on raw material and freight prices, as well as mitigation
strategies developed in response thereto) and technological factors outside of
Axalta’s control, as well as risks related to the execution of, and assumptions
underlying, our tariff mitigation strategies, our capital allocation strategy
and future share repurchases, our previously-announced global transformation
initiative, our previously-announced three-year 2024-2026 strategy, the Proposed
Merger (including our ability to consummate the Proposed Merger and realize the
anticipated benefits thereof) and our planned divestiture of our North America
Building Products business that may cause its business, industry, strategy,
financing activities or actual results to differ materially. More information on
potential factors that could affect Axalta’s financial results is available in
“Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” within Axalta’s most
recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and in
other documents that we have filed with, or furnished to, the U.S. Securities
and Exchange Commission (the “SEC”). More information on these risks, as well as
other risks associated with the Proposed Merger, are also discussed in the
definitive proxy statement/prospectus relating to the Proposed Merger, which was
filed with the SEC on June 24, 2026. Axalta undertakes no obligation to update
or revise any of the forward-looking statements contained herein, whether as a
result of new information, future events or otherwise.
Non-GAAP Financial Measures
This release includes financial information that is not presented in accordance
with generally accepted accounting principles in the United States (“GAAP”),
including Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS,
adjusted net income, Free Cash Flow, total net leverage ratio (or “total net
leverage”), tax rate, as adjusted, and Adjusted EBIT. Management uses Adjusted
EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, tax
rate, as adjusted, and Adjusted EBIT in the analysis of our financial and
operating performance because they assist in the evaluation of underlying trends
in our business. Management uses Free Cash Flow and total net leverage ratio in
the analysis of (1) our liquidity, (2) our ability to incur and service our debt
and (3) strategic capital allocation decisions. Adjusted EBITDA, Adjusted
Diluted EPS, adjusted net income and Adjusted EBIT consist of EBITDA, Diluted
EPS, net income attributable to common shareholders and EBIT, respectively,
adjusted for (i) certain non-cash items included within net income, (ii) certain
items Axalta does not believe are indicative of ongoing operating performance or
(iii) certain nonrecurring, unusual or infrequent items that have not otherwise
occurred within the last two years or we believe are not reasonably likely to
recur within the next two years. Free Cash Flow consists of cash provided by
(used for) operating activities less purchase of property, plant and equipment
plus interest proceeds on swaps designated as net investment hedges. Total net
leverage ratio consists of net debt divided by Adjusted EBITDA, with net debt
defined as total debt less cash and cash equivalents. We believe that making the
foregoing adjustments provides investors meaningful information to understand
our operating results and ability to analyze financial and business trends on a
period-to-period basis. The non-GAAP financial measures used by Axalta may
differ from similarly titled measures reported by other companies. Adjusted
EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, Free
Cash Flow, total net leverage ratio, tax rate, as adjusted, and Adjusted EBIT
should not be considered as alternatives to net sales, net income (loss), income
(loss) from operations or any other financial measures derived in accordance
with GAAP. These non-GAAP financial measures have important limitations as
analytical tools and should be considered in conjunction with, and not as
substitutes for, our results as reported under GAAP. This release includes a
reconciliation of certain non-GAAP financial measures with the most directly
comparable financial measures calculated in accordance with GAAP. Axalta does
not provide a reconciliation for Adjusted EBITDA, Adjusted Diluted EPS, tax
rate, as adjusted, or Free Cash Flow on a forward-looking basis because the
information necessary to calculate a meaningful or accurate estimation of
reconciling items is not available without unreasonable effort. For example,
such reconciling items include the impact of foreign currency exchange gains or
losses, gains or losses that are unusual or nonrecurring in nature, as well as
discrete taxable events. These items are uncertain, depend on various factors
and may have a substantial and unpredictable impact on our GAAP results.
Segment Financial Measures
The primary measure of segment operating performance is Adjusted EBITDA, which
is a key metric that is used by management to evaluate business performance in
comparison to budgets, forecasts and prior year financial results and that
management believes reflects Axalta’s core operating performance. As we do not
measure segment operating performance
3
based on net income, a reconciliation of this non-GAAP financial measure with
the most directly comparable financial measure calculated in accordance with
GAAP is not available.
Defined Terms
All capitalized terms contained within this release that are not otherwise
defined herein have been previously defined in our filings with the SEC.
Rounding
Certain amounts may not foot or crossfoot due to rounding. Additionally, certain
percentages may not recalculate due to rounding.
General Restrictions
This communication is not for release, publication, or distribution, in whole or
in part, in or into, directly or indirectly, any jurisdiction in which such
release, publication, or distribution would be unlawful.
This communication is not a prospectus and the information in this communication
is not intended to be complete. This communication is for informational purposes
only and is not intended to be and shall not constitute a solicitation of any
vote or approval, or an offer to buy or sell, or the solicitation of an offer to
buy or sell, any securities, or an invitation or recommendation to subscribe
for, acquire or buy securities of Axalta or AkzoNobel or any other financial
products or securities, in any place or jurisdiction, nor shall there be any
offer, solicitation or sale of securities in any jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction. No offer of
securities shall be made except by means of a prospectus meeting the
requirements of Section 10 of the U.S. Securities Act of 1933, as amended (the
“Securities Act”).
Any decision to purchase, subscribe for, otherwise acquire, sell or otherwise
dispose of any securities must be made only on the basis of the information
contained in and incorporated by reference into the prospectus with respect to
the shares to be allotted by AkzoNobel in the Proposed Merger, which was
published on June 24, 2026 and supplemented on July 22, 2026.
The distribution of this communication may, in some countries, be restricted by
law or regulation. Accordingly, persons who come into possession of this
document should inform themselves of and observe these restrictions. To the
fullest extent permitted by applicable law, Axalta and AkzoNobel disclaim any
responsibility or liability for the violation of any such restrictions by any
person. Neither Axalta, nor AkzoNobel, nor any of their advisors assume any
responsibility for any violation by any person of any of these restrictions.
Shareholders of Axalta and AkzoNobel, respectively, with any doubt as to their
position should consult an appropriate professional advisor without delay.
This communication is addressed to and directed only at (i) persons who are
outside the United Kingdom, (ii) persons having professional experience in
matters relating to investments falling within Article 19(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the
“Order”), (iii) persons falling within Article 49(2)(a) to (d) of the Order, or
(iv) persons to whom it may otherwise lawfully be communicated pursuant to the
Order (all such persons together being referred to as, “Relevant Persons”). This
communication is directed only at Relevant Persons. Other persons should not act
or rely on this communication or any of its contents. Any investment or
investment activity to which this communication relates is available only to
Relevant Persons and will be engaged in only with such persons. Solicitations
resulting from this communication will only be responded to if the person
concerned is a Relevant Person.
Additional Information and Where to Find It
In connection with the Proposed Merger between Axalta and AkzoNobel, AkzoNobel
filed with the SEC a registration statement on Form F-4 on May 27, 2026, as
amended on June 18, 2026, which included a proxy statement of Axalta that also
constitutes a prospectus with respect to the shares to be offered by AkzoNobel
in the Proposed Merger. The registration statement was declared effective by the
SEC on June 23, 2026. In connection with the proposed transaction, on June 24,
2026, Axalta filed with the SEC a definitive proxy statement and, on or about
June 24, 2026, Axalta commenced mailing the definitive proxy statement to its
holders of record as of June 11, 2026. On August 5, 2026, shareholders at the
Extraordinary General Meeting of AkzoNobel and the Special General Meeting of
Axalta, respectively, voted in favor of all resolutions related to the Proposed
Merger. Each of Axalta and AkzoNobel will also file other relevant documents in
connection with the Proposed Merger. This communication is not a substitute for
any registration statement, proxy statement/prospectus or other documents Axalta
and/or AkzoNobel may file with the SEC or any other competent regulator in
connection with the Proposed Merger. This communication does not contain all the
information that should be considered concerning the Proposed Merger and is not
intended to form the basis of any investment decision or any other decision in
respect of the Proposed Merger. BEFORE MAKING ANY VOTING OR INVESTMENT
DECISIONS, INVESTORS, STOCKHOLDERS AND
4
SHAREHOLDERS OF AXALTA AND AKZONOBEL ARE URGED TO READ CAREFULLY AND IN THEIR
ENTIRETY THE PROXY STATEMENT/PROSPECTUS, AS APPLICABLE, AND ANY OTHER RELEVANT
DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY
AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, IN CONNECTION WITH THE PROPOSED
TRANSACTION WHEN THEY BECOME AVAILABLE, AS THEY CONTAIN OR WILL CONTAIN
IMPORTANT INFORMATION ABOUT AXALTA, AKZONOBEL, THE PROPOSED TRANSACTION AND
RELATED MATTERS. The registration statement and proxy statement/prospectus and
other relevant documents filed by Axalta and AkzoNobel with the SEC are
available free of charge at the SEC’s website at www.sec.gov. In addition,
investors and shareholders will be able to obtain free copies of the proxy
statement/prospectus and other documents filed with the SEC from Axalta’s
investor relations webpage at https://ir.axalta.com/sec-filings/all-sec-filings
or from AkzoNobel’s investor relations webpage at
https://www.akzonobel.com/en/investors/all-sec-filings.
The contents of this communication should not be construed as financial, legal,
business, investment, tax or other professional advice. Each recipient should
consult with its own professional advisors for any such matter and advice
About Axalta Coating Systems
Axalta is a global leader in the coatings industry, providing customers with
innovative, colorful, beautiful and sustainable coatings solutions. From light
vehicles, commercial vehicles and refinish applications to electric motors,
building facades and other industrial applications, our coatings are designed to
prevent corrosion, increase productivity and enhance durability. With more than
150 years of experience in the coatings industry, the global team at Axalta
continues to find ways to serve our more than 100,000 customers in over 140
countries better every day with the finest coatings, application systems and
technology. For more information visit axalta.com and follow us @axalta on X.
5
Financ…
Statem…
Tables
AXALTA
COATING
SYSTEMS
LTD.
Conden…
Consol…
Statem…
of
Operat…
(Unaud…
(In
millio…
except
per
share
data)
Three Nine
Months Months
Ended Ended
September Septemb…
30, 30,
2026 2025 2026 2025
Net $ 1,311 $ 1,288 $ 3,911 $ 3,855
sales
Cost of
goods 877 838 2,596 2,515
sold
Sellin…
general
and 201 197 614 607
admini…
expens…
Other
operat… 24 6 92 32
charges
Resear…
and 18 18 54 55
develo…
expens…
Amorti…
of 26 25 77 73
acquir…
intang…
Income
from 165 204 478 573
operat…
Intere…
expens… 37 45 112 134
net
Other
expense — 4 -1 12
(incom…
net
Income
before 128 155 367 427
income
taxes
Provis…
for 33 45 92 108
income
taxes
Net 95 110 275 319
income
Less:
Net
income
attrib… — — 1 1
to
noncon…
intere…
Net
income
attrib… $ 95 $ 110 $ 274 $ 318
to
common
shareh…
Basic
net
income $ 0.44 $ 0.51 $ 1.28 $ 1.47
per
share
Diluted
net
income $ 0.44 $ 0.51 $ 1.28 $ 1.46
per
share
Basic
weight…
average 214.0 215.0 213.9 216.9
shares
outsta…
Diluted
weight…
average 215.1 215.9 214.8 217.9
shares
outsta…
6
AXALTA COATING
SYSTEMS LTD.
Condensed
Consolidated
Balance Sheets
(Unaudited)
(In millions,
except per share
data)
Assets
Current assets: September 30, 2026 December 31, 2025
──────────────────────────────────────────────────────────────────────────────
Cash and cash $ 650 $ 657
equivalents
Restricted cash 6 3
Accounts and
notes receivable, 1,366 1,229
net
Inventories 849 756
Prepaid expenses
and other current 192 170
assets
Total current 3,063 2,815
assets
Property, plant
and equipment, 1,319 1,299
net
Goodwill 1,762 1,795
Identifiable 1,056 1,147
intangibles, net
Other assets 547 543
Total assets $ 7,747 $ 7,599
Liabilities,
Shareholders’
Equity
Current
liabilities:
Accounts payable $ 780 $ 637
Current portion 519 20
of borrowings
Other accrued 701 712
liabilities
Total current 2,000 1,369
liabilities
Long-term 2,476 3,179
borrowings
Accrued pensions 225 238
Deferred income 182 171
taxes
Other liabilities 198 249
Total liabilities 5,081 5,206
Shareholders’
equity:
Common shares,
$1.00 par,
1,000.0 shares
authorized, 255.7
and 255.1 shares
issued at 256 255
September 30,
2026 and
December 31,
2025,
respectively
Capital in excess 1,637 1,621
of par
Retained earnings 2,329 2,055
Treasury shares,
at cost, 41.7
shares at
both September -1,202 -1,202
30, 2026 and
December 31,
2025
Accumulated other
comprehensive -400 -383
loss
Total Axalta
shareholders’ 2,620 2,346
equity
Noncontrolling 46 47
interests
Total
shareholders’ 2,666 2,393
equity
Total liabilities
and shareholders’ $ 7,747 $ 7,599
equity
7
AXALTA COATING SYSTEMS LTD.
Condensed Consolidated Statements
of Cash Flows (Unaudited) Nine Months Ended
(In millions) September 30,
Operating activities: 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net income $ 275 $ 319
Adjustment to reconcile net income
to
cash provided by operating
activities:
Depreciation and amortization 233 218
Amortization of deferred financing
costs 6 6
and original issue discount
Deferred income taxes 24 28
Realized and unrealized foreign
exchange -8 31
(gains) losses, net
Stock-based compensation 23 19
Interest income on swaps designated
as -9 -9
net investment hedges
Other non-cash, net -2 8
Changes in operating assets and
liabilities:
Trade accounts and notes receivable -132 -48
Inventories -99 -53
Prepaid expenses and other assets -75 -132
Accounts payable 146 -15
Other accrued liabilities 2 -71
Other liabilities -29 4
Cash provided by operating 355 305
activities
Investing activities:
Acquisitions, net of cash acquired -8 -6
Purchase of property, plant and -144 -138
equipment
Interest proceeds on swaps
designated as 9 9
net investment hedges
Proceeds received on loans to 8 6
customers
Other investing activities, net -3 7
Cash used for investing activities -138 -122
Financing activities:
Payments on long-term borrowings -211 -25
Purchases of common stock — -165
Net cash flows associated with -7 -3
stock-based awards
Other financing activities, net -3 -2
Cash used for financing activities -221 -195
Decrease in cash -4 -12
Effect of exchange rate changes on — 26
cash
Cash at beginning of period 660 596
Cash at end of period $ 656 $ 610
Cash at end of period
reconciliation:
Cash and cash equivalents $ 650 $ 606
Restricted cash 6 4
Cash at end of period $ 656 $ 610
8
The following table reconciles net income to EBITDA, Adjusted EBITDA and segment
Adjusted EBITDA for the periods presented (in millions):
… …
… … N… Y…
… … M… E…
… … E… D…
… … S… 3…
… … … … 3… 2… 2…
──────────────────────────────────────────────────────────────────────────────
$ … $ … $ 3… $ … $ … $ …
… … 1… … … …
… … 1… … … …
… … 3… … … …
… … 9… … … …
5 2 12 … … …
… 5 97 … … …
1 1 5 5 6 6
2 4 11 7 … …
3 3 14 … 9 …
8 6 29 … … …
— … -1 — … …
… 4 1 1 4 4
$ … $ … $ 1… $ … $ … $ …
$ … $ … $ 5… $ … $ … $ …
… % … % 6… % … % … % … %
… % … % 2… % … % … % … %
$ … $ … $ 7… $ … $ … $ …
… … 3… … … …
$ … $ … $ 1… $ … $ … $ …
Represents expenses and associated changes to estimates related to
employee termination benefits, consulting, legal and other
(a) employee-related costs associated with restructuring programs and
other employee-related costs. We do not consider these amounts
indicative of our ongoing operating performance.
Represents merger and acquisition-related expenses, including costs
(b) related to financial, tax and legal advisory services, associated
with both consummated and unconsummated transactions, all of which we
do not consider indicative of our ongoing operating performance.
Represents costs related to the closure of certain manufacturing
(c) sites, including impairment charges, which we do not consider
indicative of our ongoing operating performance.
Represents foreign exchange losses resulting from the remeasurement
(d) of assets and liabilities denominated in foreign currencies, net of
the impacts of our foreign currency instruments used to hedge our
balance sheet exposures.
(e) Represents the non-cash, non-service cost components of long-term
employee benefit costs.
(f) Represents non-cash impacts associated with stock-based compensation.
Represents non-recurring income related to the sales of certain fixed
(g) assets, which are not considered indicative of our ongoing
performance.
Represents (benefits) costs for certain non-operational or non-cash
(h) (gains) losses, net, unrelated to our core business and which we do
not consider indicative of our ongoing operating performance.
9
The following table reconciles net income to adjusted net income for the periods
presented (in millions, except per share data):
Three Nine
Months Months
Ended Ended
September September
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Net $ 95 $ 110 $ 275 $ 319
income
Less:
Net
income
attribu… — — 1 1
to
noncont…
interes…
Net
income
attribu… 95 110 274 318
to
common
shareho…
Termina…
benefits
and 5 2 11 22
other
employe…
costs(a)
Merger
and 19 5 76 11
acquisi…
costs(b)
Acceler…
depreci…
and site 1 1 5 8
closure
costs(c)
Other -2 -2 2 -1
adjustm…
Amortiz…
of 26 25 77 73
acquired
intangi…
Total 49 31 171 113
adjustm…
Income
tax 8 -3 36 19
provisi…
impacts…
Adjusted
net $ 136 $ 144 $ 409 $ 412
income
Adjusted
diluted
net $ 0.63 $ 0.67 $ 1.91 $ 1.89
income
per
share
Diluted
weighted
average 215.1 215.9 214.8 217.9
shares
outstan…
Represents expenses and associated changes to estimates related to
employee termination benefits, consulting, legal and other
(a) employee-related costs associated with restructuring programs and
other employee-related costs. We do not consider these amounts
indicative of our ongoing operating performance.
Represents merger and acquisition-related expenses, including costs
(b) related to financial, tax and legal advisory services, associated
with both consummated and unconsummated transactions, all of which we
do not consider indicative of our ongoing operating performance.
Represents incremental depreciation expense resulting from truncated
useful lives of the assets impacted by our manufacturing footprint
(c) assessments and costs related to the closure of certain manufacturing
sites, including impairment charges, which we do not consider
indicative of our ongoing operating performance.
Represents (benefits) costs for certain non-operational or non-cash
(d) (gains) losses, net, unrelated to our core business and which we do
not consider indicative of our ongoing operating performance.
(e) Represents non-cash amortization expense for intangible assets
acquired through business combinations or asset acquisitions.
The income tax impacts are determined using the applicable rates in
the taxing jurisdictions in which expense or income occurred and
includes both current and deferred income tax expense (benefit) based
(f) on the nature of the non-GAAP performance measure. Additionally, the
income tax impact includes the removal of discrete income tax impacts
within our effective tax rate which were benefits of $0 million and
$12 million and expenses of $10 million and $6 million for the three
and nine months ended September 30, 2026 and 2025, respectively.
10
The following table reconciles cash provided by operating activities to free
cash flow for the periods presented (in millions):
T… T… T… N…
M… M… M… M…
E… E… E… E…
M… J… S… S…
2… 3… 2… 2… 3… … … 3… … … 3… …
──────────────────────────────────────────────────────────────────────────────
…
…
… $ 68 $ 26 $ 1… $ 1… $ 1… $ 1… $ 3… $ 3…
…
…
…
…
… -… -… -… -… -… -… -… -…
…
…
…
…
…
…
…
… 3 3 3 4 3 2 9 9
…
…
…
…
…
… $ 21 $ -… $ 1… $ 1… $ 92 $ 89 $ 2… $ 1…
…
11
The following table reconciles income from operations to adjusted EBIT for the
periods presented (in millions):
Three Nine
Months Months
Ended Ended
September September
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Income
from $ 165 $ 204 $ 478 $ 573
operatio…
Other
expense — 4 -1 12
(income),
net
Total 165 200 479 561
Terminat…
benefits
and other 5 2 11 22
employee…
costs(a)
Merger
and 19 5 76 11
acquisit…
costs(b)
Accelera…
deprecia…
and site 1 1 5 8
closure
costs(c)
Other -2 -2 2 -1
adjustme…
Amortiza…
of 26 25 77 73
acquired
intangib…
Adjusted $ 214 $ 231 $ 650 $ 674
EBIT
Represents expenses and associated changes to estimates related to
employee termination benefits, consulting, legal and other
(a) employee-related costs associated with restructuring programs and
other employee-related costs. We do not consider these amounts
indicative of our ongoing operating performance.
Represents merger and acquisition-related expenses, including costs
(b) related to financial, tax and legal advisory services, associated
with both consummated and unconsummated transactions, all of which we
do not consider indicative of our ongoing operating performance.
Represents incremental depreciation expense resulting from truncated
useful lives of the assets impacted by our manufacturing footprint
(c) assessments and costs related to the closure of certain manufacturing
sites, including impairment charges, which we do not consider
indicative of our ongoing operating performance.
Represents (benefits) costs for certain non-operational or non-cash
(d) (gains) losses, net, unrelated to our core business and which we do
not consider indicative of our ongoing operating performance.
(e) Represents non-cash amortization expense for intangible assets
acquired through business combinations or asset acquisitions.
12